Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.06% Nasdaq Down 0.01%
Streaming
Ticker Tape: On

More On BLRX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BioLineRx, Ltd. (BLRX)

-NasdaqCM

1.63 Down 0.05(2.98%) May 24, 3:59PM EDT

Add to Portfolio
Prev Close:1.68
Open:1.68
Bid:N/A
Ask:1.71 x 9900
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1.62 - 1.68
52wk Range:1.55 - 5.10
Volume:35,635
Avg Vol (3m):212,066
Market Cap:34.88M
P/E (ttm):N/A
EPS (ttm):-1.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BLRX

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioLineRx Ltd., a clinical stage biopharmaceutical development company, engages in identifying, in-licensing, and developing therapeutic candidates. The company’s development pipeline consists of six clinical-stage therapeutic candidates, inc... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback